We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes.
- Authors
Rosenstock, Julio; Cappelleri, Joseph C.; Bolinder, Björn; Gerber, Robert A.
- Abstract
The aim of this study was to determine patient satisfaction in patients with type 1 or type 2 diabetes receiving an inhaled insulin or subcutaneous insulin regimen, as assessed by pooled analysis of two 12-week parent studies and 1-year extension studies. Of the 60 patients who received inhaled insulin during the parent studies, 85.0% (n = 51) chose to continue treatment, 13.3% (n = 8) switched to subcutaneous insulin, and 1.7% (n = 1) did not continue. Of the 61 patients who received subcutaneous insulin, 21.3% (n = 13) chose to continue treatment, 75.4% (n = 46) switched to inhaled insulin, and 3.3% (n = 2) did not continue. From baseline (parent studies) to 1 year (extension studies), HbA1c reductions of 0.8% were sustained, and greater improvements were observed in the inhaled insulin group compared with the subcutaneous insulin group in terms of overall satisfaction (37.9 vs. 3.1%; P < 0.01) and ease of use (43.2 vs. -0.9%; P < 0.01). Inhaled insulin was preferred over subcutaneous insulin, which resulted in greater patient satisfaction up to 1 year in patients with type 1 or type 2 diabetes with durable effects on HbA1c levels.
- Subjects
DIABETES; PEOPLE with diabetes; INSULIN; PATIENT satisfaction; PATIENTS; EVALUATION of medical care
- Publication
Diabetes Care, 2004, Vol 27, Issue 6, p1318
- ISSN
0149-5992
- Publication type
Article
- DOI
10.2337/diacare.27.6.1318